Cargando…
Effects and mechanisms of SGLT2 inhibitors on the NLRP3 inflammasome, with a focus on atherosclerosis
Atherosclerosis is a lipid-driven chronic inflammatory disease that is widespread in the walls of large and medium-sized arteries. Its pathogenesis is not fully understood. The currently known pathogenesis includes activation of pro-inflammatory signaling pathways in the body, increased oxidative st...
Autores principales: | Yang, Liu, Zhang, Xuejiao, Wang, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797675/ https://www.ncbi.nlm.nih.gov/pubmed/36589841 http://dx.doi.org/10.3389/fendo.2022.992937 |
Ejemplares similares
-
Role of the NLRP3 Inflammasome in Preeclampsia
por: Shirasuna, Koumei, et al.
Publicado: (2020) -
Role of NLRP3 Inflammasomes in Atherosclerosis
por: Karasawa, Tadayoshi, et al.
Publicado: (2017) -
Nuclear Receptors in the Control of the NLRP3 Inflammasome Pathway
por: Duez, Hélène, et al.
Publicado: (2021) -
NLRP3 Inflammasome: A New Target for Prevention and Control of Osteoporosis?
por: Jiang, Na, et al.
Publicado: (2021) -
Pyroptosis in NLRP3 inflammasome-related atherosclerosis
por: Zeng, Xiang, et al.
Publicado: (2022)